Treatment for iron overload

Israel’s Teva has launched a generic version of EXJADE (deferasirox) in the US. It treats patients two years of age and older for chronic iron overload due to blood transfusions. Currently, one in eight generic prescriptions dispensed in the U.S. is filled with a Teva generic product.

This entry was posted in Israel's Medical Achievements. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *